Innovation in Hyperinsulinemia Diagnostics with ANN-L(
ANN + orthogonal vector plans
ML algorithms
hyperinsulinemia
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
20 Feb 2023
20 Feb 2023
Historique:
received:
10
01
2023
revised:
11
02
2023
accepted:
12
02
2023
entrez:
25
2
2023
pubmed:
26
2
2023
medline:
26
2
2023
Statut:
epublish
Résumé
Hyperinsulinemia is a condition characterized by excessively high levels of insulin in the bloodstream. It can exist for many years without any symptomatology. The research presented in this paper was conducted from 2019 to 2022 in cooperation with a health center in Serbia as a large cross-sectional observational study of adolescents of both genders using datasets collected from the field. Previously used analytical approaches of integrated and relevant clinical, hematological, biochemical, and other variables could not identify potential risk factors for developing hyperinsulinemia. This paper aims to present several different models using machine learning (ML) algorithms such as naive Bayes, decision tree, and random forest and compare them with a new methodology constructed based on artificial neural networks using Taguchi's orthogonal vector plans (ANN-L), a special extraction of Latin squares. Furthermore, the experimental part of this study showed that ANN-L models achieved an accuracy of 99.5% with less than seven iterations performed. Furthermore, the study provides valuable insights into the share of each risk factor contributing to the occurrence of hyperinsulinemia in adolescents, which is crucial for more precise and straightforward medical diagnoses. Preventing the risk of hyperinsulinemia in this age group is crucial for the well-being of the adolescents and society as a whole.
Identifiants
pubmed: 36832286
pii: diagnostics13040798
doi: 10.3390/diagnostics13040798
pmc: PMC9955502
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Arq Bras Endocrinol Metabol. 2008 Dec;52(9):1466-73
pubmed: 19197455
J Endocr Soc. 2019 Jul 24;3(9):1727-1747
pubmed: 31528832
Diabetologia. 2020 Mar;63(3):462-472
pubmed: 31915891
Nutrients. 2022 Nov 19;14(22):
pubmed: 36432582
Endocrine. 2021 Apr;72(1):116-123
pubmed: 33502730
Soft comput. 2023;27(5):2635-2643
pubmed: 32904395
Endocrine. 2022 Dec 2;:
pubmed: 36459334
Med Biol Eng Comput. 2019 Jan;57(1):193-203
pubmed: 30076537
Endocrinol Diabetes Nutr (Engl Ed). 2022 May;69(5):354-361
pubmed: 35697467
J Bodyw Mov Ther. 2021 Jul;27:55-59
pubmed: 34391285
Cancer Biol Med. 2021 Dec 22;:
pubmed: 34931768
J Ambient Intell Humaniz Comput. 2022;13(1):41-73
pubmed: 33469467
Pediatr Obes. 2022 Jan;17(1):e12841
pubmed: 34382374
Appl Soft Comput. 2020 Nov;96:106691
pubmed: 33519327
BMC Med. 2020 Nov 25;18(1):361
pubmed: 33234146
Entropy (Basel). 2021 Jul 02;23(7):
pubmed: 34356395
Clin Diabetes Endocrinol. 2022 Mar 15;8(1):3
pubmed: 35296370
Comput Biol Med. 2022 Jun;145:105458
pubmed: 35364311
Rev Endocr Metab Disord. 2020 Dec;21(4):577-597
pubmed: 32185602
J Cancer Surviv. 2021 Oct;15(5):792-798
pubmed: 33230725
Diabetologia. 2021 May;64(5):1016-1029
pubmed: 33710398